𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Anxiety and depression in patients with inflammatory bowel disease: Comparisons with chronic liver disease patients and the general population

✍ Scribed by Winfried Häuser; Karl-Heinz Janke; Bodo Klump; Andreas Hinz

Publisher
John Wiley and Sons
Year
2011
Tongue
English
Weight
126 KB
Volume
17
Category
Article
ISSN
1078-0998

No coin nor oath required. For personal study only.

✦ Synopsis

Background: Studies on anxiety and depression in inflammatory bowel disease (IBD) yielded inconsistent results. We compared anxiety and depression of patients with Crohn's disease (CD) and ulcerative colitis (UC) controlled for sociodemographic and medical variables with age-and sex-matched controls.

Methods: In all, 422 IBD patients (50% females, 314 CD, 108 UC) of different settings were compared with 140 age-and sexmatched patients with chronic liver diseases (CLD) of a tertiary care center and with 422 age-and sex-matched persons of a representative sample of the general German population (GP). Anxiety and depression and probable mental disorder were assessed by the German version of the Hospital Anxiety and Depression Scale. Comparisons between CD and UC were adjusted for medical (disease activity, number of IBD-associated diseases) and sociodemographic factors (age, gender, marital status).

Results: CD and UC patients did not differ in the levels of anxiety and depression or in the frequency of a probable mental disorder. The levels of anxiety and depression of IBD patients with active disease were higher than that of the GP, but not of the IBD patients in remission. The depression score of the CLD sample was higher than that of the IBD sample (P < 0.001), but not the anxiety score. Mental disorders were more frequent in IBD patients with slight (27.7%) and moderate/severe disease activity (49.3%) compared to GP (10.4%) (P < 0.001), but not in IBD patients in remission (11.3%).

Conclusions:

Patients with active IBD should be screened for anxiety and depression.

📜 SIMILAR VOLUMES

MRI in patients with inflammatory bowel
MRI in patients with inflammatory bowel disease
✍ Michael S. Gee; Mukesh G. Harisinghani 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 339 KB

## Abstract Inflammatory bowel disease (IBD) affects ≈1.4 million people in North America and, because of its typical early age of onset and episodic disease course, IBD patients often undergo numerous imaging studies over the course of their lifetimes. Computed tomography (CT) has become the stand

Immunizations in patients with inflammat
Immunizations in patients with inflammatory bowel disease
✍ Ying Lu; Denise Jacobson; Athos Bousvaros 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 94 KB 👁 1 views

Patients receiving immunosuppressive therapies may be at increased risk for complications of vaccine preventable diseases, including influenza, varicella, and pneumococcus. However, studies suggest that patients with chronic illness may be inadequately immunized. In part, this is because of a paucit

Controversies surrounding the comorbidit
Controversies surrounding the comorbidity of depression and anxiety in inflammatory bowel disease patients: A literature review
✍ Antonina A. Mikocka-Walus; Deborah A. Turnbull; Nicole T. Moulding; Ian G. Wilso 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 106 KB 👁 1 views

Psychological disorders are highly prevalent in patients with inflammatory bowel disease (IBD). Anxiety and depression are known to independently affect quality of life and may additionally impair quality of life in IBD over and above the IBD itself. Some researchers have further proposed that anxie